Location(s):West Germany

Level of position:Senior Manager

Position type:Field-based

Reporting Line:Sales Director, Germany

How will your role help us transform hope into reality?

The position will be part of a broader KAM team in Germany, responsible for maintaining and establishing new connections with HCPs (hematologists and dermatologist) in the West region of Germany.

What will you do?

Want more jobs like this?GetAccount Managementjobsdelivered to your inbox every week.

Want more jobs like this?

GetAccount Managementjobsdelivered to your inbox every week.

Select a locationGet Jobs

Select a location

What qualifications do we require?

Account Management

Stakeholder Engagement

Cross-Functional Team Leadership

Operational Excellence

What additional qualifications will make you a stronger candidate?

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Blueprint Medicines is a fully integrated, commercial-stage, global biopharmaceutical company that invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. We pursue discovery, development, and commercialization of therapies that potently and selectively target known drivers of disease, with focused investment in therapeutic areas where we can leverage our core expertise and business infrastructure to bring scale to our science. We are bringing an approved medicine to people living with systemic mastocytosis (SM) in the U.S. and Europe. Additionally, we have a pipeline of research and development programs that range from early science to advanced clinical trials in mast cell-mediated diseases, including SM and chronic urticaria, breast cancer, and other solid tumors vulnerable to CDK2 inhibition.

#LI-Remote

#LI-NJ1